Federal contract award
15B50526F00000159
EXELAN, LENALIDOMIDE 10MG CAP, ORAL $466.51 X 14 DOSES $6531.14 APR FY26
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Justice |
| Office | FMC CARSWELL |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | Q517 — Pharmacy Services |
| Parent award / vehicle | 36F79720D0227 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $2.3K |
| Current contract value | $2.3K |
| Potential contract value / ceiling | $2.3K |
| Start date | Apr 1, 2026 |
| Current end date | Apr 30, 2026 |
| Potential end date | Apr 30, 2026 |
| Latest award activity | Apr 23, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Apr 23, 2026 | P00001 | $-4.3K | EXELAN, LENALIDOMIDE 10MG CAP, ORAL $466.51 X 14 DOSES $6531.14 APR FY26 |
| Apr 20, 2026 | 0 | $6.5K | EXELAN, LENALIDOMIDE 10MG CAP, ORAL $466.51 X 14 DOSES $6531.14 APR FY26 |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.